brain | MyInVitroAnswer.com

top of page

IN VITRO REVOLUTION
INDUSTRY NEWS
TECH FRONTIERS
APPLICATION EXPLORER

Subscribe to Newsletter

All Posts
Organ-on-a-chip systems
Intra-industry partnerships
Pharma & biotech collaborations
Product Launches
Clinical Trial Outcomes
M&A Activity
Bioprinting
3D tissue platforms
Clinical Trial Authorizations
Regulatory Modernizations
Organoid technologies
Grants Awarded & Funds Raised
Hybrid AI-in vitro platforms

Autologous human tumor-immune organoid model for patient-specific prediction of response to immunotherapy

Autologous human tumor-immune organoid model for patient-specific prediction of response to immunotherapy

Autologous human tumor-immune organoid model for patient-specific prediction of response to immunotherapy

Organoid technologies

A person sketched in black and white colour holds their head, looking troubled. His thoughts are visually represented by blue lines that intersect chaotically, suggesting the person suffers from cognitive impairment related to Alzheimer's disease. Beneath his eyes, 6 abstract pattern lines of different blue shades progress toward him. These lines symbolize the 6 distinct hiPSC-derived cell lines that researchers have used to engineer a 3D immuno-glial-neurovascular human brain model for preclinical research into neurodegenerative disorders.

A person sketched in black and white colour holds their head, looking troubled. His thoughts are visually represented by blue lines that intersect chaotically, suggesting the person suffers from cognitive impairment related to Alzheimer's disease. Beneath his eyes, 6 abstract pattern lines of different blue shades progress toward him. These lines symbolize the 6 distinct hiPSC-derived cell lines that researchers have used to engineer a 3D immuno-glial-neurovascular human brain model for preclinical research into neurodegenerative disorders.

3D immuno-glial-neurovascular human brain platform for high-fidelity disease modelling

3D tissue platforms

Hesperos awarded Phase IIB SBIR grant to investigate drug-induced cognitive impairment using its Human-on-a-Chip®

Grants Awarded & Funds Raised

Terms and Conditions

© Copyright Sania Ristic 2025. All rights reserved.

bottom of page